Literature DB >> 7561970

Diagnosing Alzheimer's disease in elderly, mildly demented patients: the impact of routine single photon emission computed tomography.

W A Van Gool1, G J Walstra, S Teunisse, F M Van der Zant, H C Weinstein, E A Van Royen.   

Abstract

Based on the observation of bilateral temporoparietal hypoperfusion in Alzheimer's disease (AD), single photon emission computed tomography (SPECT) is advocated by some as a powerful diagnostic tool in the evaluation of demented patients. We studied whether routine brain SPECT in elderly, mildly demented outpatients increases the a priori diagnostic sensitivity and specificity of a careful clinical examination. 99mTc-HMPAO SPECT imaging was performed in 110 patients for a first evaluation for dementia. A semiquantitative measure of temporoparietal (TP) perfusion was calculated as the ratio of the activity in the temporoparietal cortex to activity in the cerebellum. A diagnosis of probable AD according to the McKhann criteria was made in 68 patients (mean age of 79.3 years) based on the results of a clinical examination, ancillary investigations and a 6-month follow-up. TP perfusion was significantly lower in AD patients than in 18 age-matched, non-demented controls. However, at a specificity of 89%, sensitivity was only 43% for detecting probable AD. The clinicians judged that SPECT had contributed to the final diagnosis in only 8% of the demented patients investigated. Routine brain SPECT in elderly, mildly demented outpatients does not contribute substantially to diagnostic accuracy after a careful clinical examination using current diagnostic criteria. Clinical guidelines have to be developed for the use of SPECT in patients with (suspected) dementia.

Entities:  

Mesh:

Year:  1995        PMID: 7561970     DOI: 10.1007/BF00868397

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  29 in total

Review 1.  Functional brain SPECT: the emergence of a powerful clinical method.

Authors:  B L Holman; M D Devous
Journal:  J Nucl Med       Date:  1992-10       Impact factor: 10.057

2.  A study of depression in old age using single-photon emission computerised tomography.

Authors:  A K Upadhyaya; M T Abou-Saleh; K Wilson; S J Grime; M Critchley
Journal:  Br J Psychiatry Suppl       Date:  1990

3.  Alzheimer disease: quantitative analysis of I-123-iodoamphetamine SPECT brain imaging.

Authors:  R S Hellman; R S Tikofsky; B D Collier; R G Hoffmann; D W Palmer; S L Glatt; P G Antuono; A T Isitman; R A Papke
Journal:  Radiology       Date:  1989-07       Impact factor: 11.105

Review 4.  Neuro-imaging in the diagnosis of Alzheimer's disease. II. Positron and single photon emission tomography.

Authors:  H C Weinstein; P Scheltens; A Hijdra; E A van Royen
Journal:  Clin Neurol Neurosurg       Date:  1993-06       Impact factor: 1.876

5.  CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia.

Authors:  M Roth; E Tym; C Q Mountjoy; F A Huppert; H Hendrie; S Verma; R Goddard
Journal:  Br J Psychiatry       Date:  1986-12       Impact factor: 9.319

6.  Single photon emission tomography using 99mTc-HM-PAO in the investigation of dementia.

Authors:  D Neary; J S Snowden; R A Shields; A W Burjan; B Northen; N MacDermott; M C Prescott; H J Testa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-09       Impact factor: 10.154

7.  Measurements of regional cerebral blood flow and cognitive performance in Alzheimer's disease.

Authors:  D Montaldi; D N Brooks; J H McColl; D Wyper; J Patterson; E Barron; J McCulloch
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-01       Impact factor: 10.154

8.  Single photon emission computed tomography using 99Tcm-HMPAO in Alzheimer's disease.

Authors:  H C Liu; R S Liu; K N Lin; S J Wang; J L Fuh; S H Yeh; B N Chiang
Journal:  Nucl Med Commun       Date:  1992-07       Impact factor: 1.690

9.  Single photon emission computed tomography in Alzheimer's disease. Abnormal iofetamine I 123 uptake reflects dementia severity.

Authors:  K A Johnson; B L Holman; S P Mueller; T J Rosen; R English; J S Nagel; J H Growdon
Journal:  Arch Neurol       Date:  1988-04

10.  Patterns of regional cerebral blood flow in Alzheimer's disease.

Authors:  G M Syed; S Eagger; J O'Brien; J J Barrett; R Levy
Journal:  Nucl Med Commun       Date:  1992-09       Impact factor: 1.690

View more
  7 in total

Review 1.  Genetic PrP Prion Diseases.

Authors:  Mee-Ohk Kim; Leonel T Takada; Katherine Wong; Sven A Forner; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

2.  Brain SPET perfusion in early Alzheimer's disease: where to look?

Authors:  Ingeborg Goethals; Christophe Van De Wiele; Daniel Slosman; Rudi Dierckx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-08       Impact factor: 9.236

Review 3.  Alzheimer's disease and mild cognitive impairment.

Authors:  Brendan J Kelley; Ronald C Petersen
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

4.  Demonstration of a reduction in muscarinic receptor binding in early Alzheimer's disease using iodine-123 dexetimide single-photon emission tomography.

Authors:  J J Claus; E A Dubois; J Booij; J Habraken; J C de Munck; M van Herk; B Verbeeten; E A van Royen
Journal:  Eur J Nucl Med       Date:  1997-06

5.  A new approach for improving diagnostic accuracy in Alzheimer's disease and frontal lobe dementia utilising the intrinsic properties of the SPET dataset.

Authors:  Marco Pagani; Vassili A Kovalev; Roger Lundqvist; Hans Jacobsson; Stig A Larsson; Lennart Thurfjell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-29       Impact factor: 9.236

Review 6.  Systematic review of the diagnostic utility of SPECT imaging in dementia.

Authors:  Jing Ming Yeo; Xuxin Lim; Zubair Khan; Suvankar Pal
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-08-06       Impact factor: 5.270

7.  Correlations of hippocampal atrophy and focal low-frequency magnetic activity in Alzheimer disease: volumetric MR imaging-magnetoencephalographic study.

Authors:  Alberto Fernández; Juan Arrazola; Fernando Maestú; Carlos Amo; Pedro Gil-Gregorio; Christian Wienbruch; Tomás Ortiz
Journal:  AJNR Am J Neuroradiol       Date:  2003-03       Impact factor: 3.825

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.